Figures computed from official regulatory filings — .
Ownershipinsiders 21.51% · institutions 0%
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Nascent Biotech Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Nascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a drug to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as epithelial cancers, including lung, breast, colon, brain, and pancreas cancer. The company is developing MultiPharm, a proprietary technology platform for cancer therapy, as well as diabetes, autoimmunity, and transplantation. In addition, it develops CLNH5. Nascent Biotech, Inc. is based in North Palm Beach, Florida.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
10 buys1 sell— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Carrick Sean | Other | $17.3K | SEC | ||
| HOLDEN LOWELL THOMAS |
| Other |
| $8.6K |
| SEC |
| Karas Douglas John | Other | $5K | SEC |
| Karas Douglas John | Other | $4.9K | SEC |
| HOLDEN LOWELL THOMAStrack record | Other | $20.3K | SEC |
| Carrick Sean | Other | $40.5K | SEC |
| Carrick Sean | Other | $40.7K | SEC |
| HOLDEN LOWELL THOMAStrack record | Other | $20.3K | SEC |
| Karas Douglas John | Other | $5.2K | SEC |
| Karas Douglas John | Other | $5.2K | SEC |
| HOLDEN LOWELL THOMAStrack record | Other | $180.2K | Unusual size | SEC |
| Carrick Sean | Other | $360.4K | Unusual size | SEC |
| Carrick Sean | Gift | $48K | SEC |
| HOLDEN LOWELL THOMAStrack record | Gift | $35K | Unusual size | SEC |
| Carrick Sean | Other | $70K | SEC |
| Karas Douglas John | Other | $5.4K | SEC |
| HOLDEN LOWELL THOMAStrack record | Buy | $5.2K | conv 67Unusual size | SEC |
| HOLDEN LOWELL THOMAStrack record | Other | $34.9K | SEC |
| HOLDEN LOWELL THOMAStrack record | Gift | $84K | SEC |
| HOLDEN LOWELL THOMAStrack record | Buy | $2.8K | conv 61Unusual size | SEC |
| HOLDEN LOWELL THOMAStrack record | Buy | $2.8K | conv 61Unusual size | SEC |
| Karas Douglas John | Other | $5K | SEC |
| HOLDEN LOWELL THOMAStrack record | Award | $46.2K | SEC |
| Carrick Sean | Other | $92.4K | SEC |
| HOLDEN LOWELL THOMAStrack record | Sell | $1.3K | SEC |